Here, we report a case of monoclonal IgA-κ amyloidosis caused by an SGPL1 gene mutation, and review the literature on the potential effects of SGPL1 gene mutations on various organs, the underlying mechanism of SGPLI-related amyloidosis, and the prognosis of patients with this rare disorder. This evidence concerns the gene SGPL1 and amyloidosis.